We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+8.95%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$61.1B
AUM Growth
+$4.73B
(+8.4%)
Cap. Flow
+$390M
Cap. Flow
% of AUM
0.64%
Top 10 Holdings %
Top 10 Hldgs %
17.66%
Holding
2,331
New
154
Increased
918
Reduced
1,058
Closed
154
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$144M |
| 2 |
Cisco
CSCO
|
+$123M |
| 3 |
Moderna
MRNA
|
+$120M |
| 4 |
JPMorgan Chase
JPM
|
+$95.4M |
| 5 |
FedEx
FDX
|
+$86.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$124M |
| 2 |
Mastercard
MA
|
+$101M |
| 3 |
Home Depot
HD
|
+$95.7M |
| 4 |
Amazon
AMZN
|
+$74.1M |
| 5 |
Eli Lilly
LLY
|
+$72.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.6% |
| 2 | Consumer Discretionary | 14.64% |
| 3 | Healthcare | 14.47% |
| 4 | Industrials | 11.01% |
| 5 | Consumer Staples | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Applied Materials
AMAT
$428B
| $244M | 0.4% |
1,848,098
-493,210
| -21% | -$54.4M |
|
52
AbbVie
ABBV
$435B
| $243M | 0.4% |
2,256,367
-205,311
| -8% | -$22M |
|
53
Visa
V
$677B
| $217M | 0.35% |
1,023,285
-182,868
| -15% | -$38.5M |
|
54
IBM
IBM
$224B
| $216M | 0.35% |
1,699,186
+135,923
| +9% | +$16.3M |
|
55
Infosys
INFY
$50.7B
| $214M | 0.35% |
11,417,369
-1,101,352
| -9% | -$19.9M |
|
56
Old Dominion Freight Line
ODFL
$44.9B
| $210M | 0.34% |
1,746,568
+68,894
| +4% | +$7.39M |
|
57
McKesson
MCK
$101B
| $203M | 0.33% |
1,040,720
+119,884
| +13% | +$21.9M |
|
58
Medtronic
MDT
$112B
| $201M | 0.33% |
1,702,404
-58,706
| -3% | -$6.88M |
|
|
59
Eli Lilly
LLY
$1.06T
| $199M | 0.32% |
1,070,814
-369,380
| -26% | -$72.3M |
|
60
Danaher
DHR
$144B
| $196M | 0.32% |
981,566
+38,835
| +4% | +$7.89M |
|
61
Vertex Pharmaceuticals
VRTX
$126B
| $195M | 0.32% |
910,527
+350,146
| +62% | +$76.9M |
|
62
Pfizer
PFE
$153B
| $192M | 0.31% |
5,324,153
+1,030,309
| +24% | +$36.6M |
|
63
Coca-Cola
KO
$375B
| $191M | 0.31% |
3,628,044
+326,058
| +10% | +$16.4M |
|
64
Illinois Tool Works
ITW
$84.5B
| $187M | 0.31% |
845,632
+2,116
| +0.3% | +$439K |
|
65
Monster Beverage
MNST
$88.5B
| $186M | 0.3% |
4,085,032
+36,482
| +0.9% | +$1.63M |
|
|
GRMN
66
Garmin
GRMN
$60B
| $181M | 0.3% |
1,380,590
-22,262
| -2% | -$2.77M |
|
67
Vale
VALE
$62.6B
| $180M | 0.3% |
10,381,379
+1,614,324
| +18% | +$28.2M |
|
68
Colgate-Palmolive
CL
$74.4B
| $180M | 0.29% |
2,280,078
+174,935
| +8% | +$13.7M |
|
69
Humana
HUM
$46.2B
| $179M | 0.29% |
427,606
-151,551
| -26% | -$60.5M |
|
70
Blackrock
BLK
$176B
| $178M | 0.29% |
236,939
+66,809
| +39% | +$48.5M |
|
71
Mettler-Toledo International
MTD
$28.6B
| $178M | 0.29% |
153,694
-15,006
| -9% | -$17.4M |
|
72
Tyson Foods
TSN
$20.4B
| $177M | 0.29% |
2,385,024
+455,514
| +24% | +$31.4M |
|
73
Jazz Pharmaceuticals
JAZZ
$16.7B
| $176M | 0.29% |
1,073,360
+60,065
| +6% | +$9.88M |
|
74
Bristol-Myers Squibb
BMY
$132B
| $173M | 0.28% |
2,751,162
-80,939
| -3% | -$5.04M |
|
75
Public Storage
PSA
$61.3B
| $172M | 0.28% |
703,801
-44,469
| -6% | -$10.4M |
|
Similar funds
VGA
AQR Capital Management's Q1 2021 Portfolio in Review
As of Q1 2021, AQR Capital Management held 2,331 positions worth $61.1B, up 8.4% from $56.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
AQR Capital Management's Q1 2021 filing shows 154 new, 918 increased, 1,058 reduced and 154 closed positions. Its largest new stake was Janus Henderson: 506,382 shares worth $15.8M. The largest sale was Microsoft, an estimated $124M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- AQR Capital Management's largest Q1 2021 buy was Janus Henderson: 506,382 shares worth $15.8M.
- AQR Capital Management added most to Thermo Fisher Scientific in Q1 2021, an estimated $144M increase.
- AQR Capital Management's biggest Q1 2021 reduction was Microsoft, cutting an estimated $124M.
- AQR Capital Management fully exited State Street SPDR S&P 500 ETF Trust in Q1 2021, selling an estimated $39.7M.
- AQR Capital Management's ten largest holdings make up 18% of its $61.1B portfolio in Q1 2021.
- AQR Capital Management opened 154 new positions and closed 154 in Q1 2021.
- AQR Capital Management's portfolio value rose 8.4% quarter-over-quarter to $61.1B.
Based on AQR Capital Management's 13F filing for Q1 2021, filed 17 May 2021.